95% effective dosage of intranasal dexmedetomidine for sedation in pediatric pulmonary function testing

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-17013995

Enrollment

Unknown

Registered

2017-12-16

Start date

2018-01-01

Completion date

Unknown

Last updated

2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric pulmonary function testing

Interventions

Case series:sedation

Eligibility

Sex/Gender

All

Age

1 Years to 3 Years

Inclusion criteria

Inclusion criteria: A total of 70 children were selected for the lung function testing need adequate sedation in children's hospital of chongqing medical university, and the gender was not limited age was 1 ~ 3 years old

Exclusion criteria

Exclusion criteria: children combined with heart failure, pneumonia and hyperthermic

Design outcomes

Primary

Measure	Time frame
MOAA/S score;Aldrete score;	—

Secondary

Measure	Time frame
heart rate, Spo2;	—

Countries

China

Contacts

Public ContactTu Shengfen

Children's Hospital Affiliated Chongqing Medical University

519194496@qq.com+86 13983416114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026